Charles Ryhee
Stock Analyst at TD Cowen
(2.47)
# 2,488
Out of 5,033 analysts
17
Total ratings
60%
Success rate
11.09%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $82.48 | -3.01% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $787.82 | -17.24% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $154.48 | +10.05% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $7.76 | +660.31% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $157.27 | -54.22% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $8.98 | +1,993.54% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $20.18 | +43.71% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $82.48
Upside: -3.01%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $787.82
Upside: -17.24%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $154.48
Upside: +10.05%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $7.76
Upside: +660.31%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $157.27
Upside: -54.22%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $8.98
Upside: +1,993.54%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $20.18
Upside: +43.71%